Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?
Prokhortchouk
Egor
E
Group of Transcriptional Control and Oncogenesis, Institute of Gene Biology, Vavilova 34/5, 117334 Moscow, Russian Federation.
Hendrich
Brian
B
D020137:Base Pair Mismatch; D002467:Cell Nucleus / Q000502:physiology; D002868:Chromosomal Proteins, Non-Histone; D003593:Cytoplasm / Q000502:physiology; D019175:DNA Methylation; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D018450:Disease Progression; D004706:Endodeoxyribonucleases / Q000235:genetics*; D005786:Gene Expression Regulation; D006801:Humans; D051783:Methyl-CpG-Binding Protein 2; D009369:Neoplasms / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics
D002868:Chromosomal Proteins, Non-Histone; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; C497392:MECP2 protein, human; D051783:Methyl-CpG-Binding Protein 2; D012097:Repressor Proteins; D004706:Endodeoxyribonucleases; C118712:MBD4 protein, human